BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 106 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q2 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $81,604,000 | +56.1% | 840,585 | +9.9% | 0.09% | +41.3% |
| Q1 2021 | $52,289,000 | +49.6% | 765,021 | +87.6% | 0.06% | +37.0% |
| Q4 2020 | $34,952,000 | +161.2% | 407,799 | +98.1% | 0.05% | +119.0% |
| Q3 2020 | $13,383,000 | -10.8% | 205,856 | +0.3% | 0.02% | -19.2% |
| Q2 2020 | $14,999,000 | +200.3% | 205,161 | +39.8% | 0.03% | +136.4% |
| Q1 2020 | $4,994,000 | -73.0% | 146,758 | -56.8% | 0.01% | -66.7% |
| Q4 2019 | $18,485,000 | -18.1% | 339,552 | -40.5% | 0.03% | -38.9% |
| Q2 2018 | $22,558,000 | +47.1% | 570,786 | -4.1% | 0.05% | +42.1% |
| Q1 2018 | $15,333,000 | +78.2% | 595,218 | +86.6% | 0.04% | +72.7% |
| Q4 2017 | $8,604,000 | – | 318,911 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 900,844 | $136,181,000 | 79.57% |
| RP Management, LLC | 1,111,111 | $167,967,000 | 77.60% |
| JET CAPITAL INVESTORS L P | 1,707,500 | $258,942,000 | 53.95% |
| Alpine Global Management, LLC | 373,999 | $56,537,000 | 13.23% |
| Chicago Capital Management, LLC | 154,585 | $23,443,000 | 12.75% |
| FIFTH LANE CAPITAL, LP | 140,000 | $21,164,000 | 11.03% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 3,784,482 | $572,100,000,000 | 10.85% |
| Eversept Partners, LP | 637,139 | $96,316,303 | 8.35% |
| EQUITEC PROPRIETARY MARKETS, LLC | 187,100 | $28,284,000 | 7.45% |
| HARVEST MANAGEMENT LLC | 48,503 | $7,332,000 | 5.92% |